Trial Profile
A Single Arm, Prospective Clinical Study Using Novel Wearable Sensors to Assess the Improvement of Nocturnal Scratch Behavior and Sleep Quality in Children With Mild-to-moderate Atopic Dermatitis Treated With Topical Crisaborole
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2023
Price :
$35
*
At a glance
- Drugs Crisaborole (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 12 Oct 2023 Status changed from active, no longer recruiting to completed.
- 27 Sep 2022 Planned End Date changed from 1 Mar 2023 to 31 Mar 2023.
- 27 Sep 2022 Status changed from recruiting to active, no longer recruiting.